Cytodyn Inc (CYDY)

[docj]

Yep, the journal needs to offset its costs by charging a very modest fee. Does not change the science or the fact is is a widely respected journal. Good for leronlimab and CYDY!

https://www.immunofrontiers.com/top-10-immunology-journals-of-2021

https://blog.frontiersin.org/2017/06/28/quality-impact-journal-analysis-frontiers-in-immunology/


Looking forward to reading future research from scientists regarding how leronlimab affects our immune response.